Table 4 The top 20 Rectome enrichment items
ID | Pathway | Enrichment_score |
|---|---|---|
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 7.99E-26 |
R-HSA-449147 | Signaling by Interleukins | 1.78E-22 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 9.26E-21 |
R-HSA-168256 | Immune System | 1.51E-15 |
R-HSA-5357801 | Programmed Cell Death | 2.85E-15 |
R-HSA-109581 | Apoptosis | 3.89E-14 |
R-HSA-162582 | Signal Transduction | 5.31E-14 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 3.26E-13 |
R-HSA-6783783 | Interleukin-10 signaling | 2.12E-12 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 5.09E-11 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 7.04E-10 |
R-HSA-1643685 | Disease | 1.13E-09 |
R-HSA-212436 | Generic Transcription Pathway | 7.37E-09 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 7.43E-09 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 7.69E-09 |
R-HSA-5218859 | Regulated Necrosis | 1.90E-08 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 2.35E-08 |
R-HSA-982772 | Growth hormone receptor signaling | 2.35E-08 |
R-HSA-73857 | RNA Polymerase II Transcription | 6.51E-08 |